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The human Werner syndrome protein (hWRN-p) pos-
sessing DNA helicase and exonuclease activities is es-
sential for genome stability. Plants have no homologue
of this bifunctional protein, but surprisingly the Arabi-
dopsis genome contains a small open reading frame
(ORF) (AtWRNexo) with homology to the exonuclease
domain of hWRN-p. Expression of this ORF in Esche-
richia coli revealed an exonuclease activity for AtWRN-
exo-p with similarities but also some significant differ-
ences to hWRN-p. The protein digests recessed strands
of DNA duplexes in the 3 3 5 direction but hardly
single-stranded DNA or blunt-ended duplexes. In con-
trast to the Werner exonuclease, AtWRNexo-p is also
able to digest 3-protruding strands. DNA with recessed
3-PO4 and 3-OH termini is degraded to a similar extent.
AtWRNexo-p hydrolyzes the 3-recessed strand termini
of duplexes containing mismatched bases. AtWRNexo-p
needs the divalent cation Mg2 for activity, which can be
replaced by Mn2. Apurinic sites, cholesterol adducts,
and oxidative DNA damage (such as 8-oxoadenine and
8-oxoguanine) inhibit or block the enzyme. Other DNA
modifications, including uracil, hypoxanthine and ethe-
noadenine, did not inhibit AtWRNexo-p. A mutation of a
conserved residue within the exonuclease domain
(E135A) completely abolished the exonucleolytic activ-
ity. Our results indicate that a type of WRN-like exonu-
clease activity seems to be a common feature of the DNA
metabolism of animals and plants.
RecQ helicases play a major role in the maintenance of
genome stability (1, 2). Unique members of the RecQ family of
DNA helicases have been found in Escherichia coli, Saccharo-
myces cerevisiae, and Schizosaccharomyces pombe. Higher eu-
karyotes like Drosophila melanogaster, Caenorhabditis el-
egans, Xenopus laevis, Mus musculus, and Homo sapiens
harbor up to five family members in their genome. In humans
several inherited diseases were correlated with mutations in
RecQ-like helicases (3–5). The most prominent disease is the
Werner syndrome (WS),1 an autosomal recessive genetic disor-
der characterized by early onset of premature aging (4) and
genomic abnormalities, such as chromosome breaks, reciprocal
chromosomal translocations (6), and extensive genomic dele-
tions (7). The Werner protein (hWRN-p) responsible for WS,
possesses 33 5 exonuclease and 33 5 helicase activities (8,
9). The 3 3 5 helicase of hWRN-p unwinds blunt-ended du-
plexes containing a single-stranded bubble and G4 DNA (10),
mediates migration of Holliday junctions (10, 11), and mediates
unwinding of DNA triple helixes with a free 3-tail of the third
strand (12) as well as of a d(CGG)7 hairpin and tetraplex
structures, which block DNA synthesis, to facilitate polymer-
ase  to traverse these unusual DNA structures and synthesize
full-length DNA products (13). Recently it has been shown that
hWRN-p helicase is able to unwind intermediates that occur
during DNA replication and repair processes such as 5-flap
substrates and synthetic replication forks (14). The hWRN-p
DNA 3 3 5 exonuclease is stimulated by ATP and digests
preferentially the recessed strand of DNA duplexes (9), three-
and four-way junctions, and substrates containing an open
helical structure, such as a loop, a stem-loop, or a bubble (15).
It can also initiate DNA degradation from a nick or a gap and
efficiently remove a mismatched nucleotide at a 3-recessed
terminus. Single-stranded DNA, blunt-end double-stranded
DNA, and DNA with a 3-protruding strand are not preferred
substrates (9, 16). However, it was shown that last two sub-
strates are exonucleolytically degraded by hWRN-p in the pres-
ence of Ku70/80, a heterodimeric factor involved in the repair of
double-strand breaks by non-homologous DNA end joining (17).
Ku70/80 also allows hWRN-p to digest regions of DNA contain-
ing 8-oxoadenine and 8-oxoguanine modifications (18), which
normally block the hWRN-p exonuclease activity (19).
WRN-like proteins have also been detected in mouse (20) and
Xenopus laevis (21). We were recently able to identify seven
RecQ homologues in Arabidopsis thaliana (22). However, no
gene encoding the complete homologue of WRN protein was
found within the Arabidopsis genome. Instead, a small ORF
(AtWRNexo) encoding 285 amino acids, lacking any RecQ-like
domain but showing a striking similarity to the exonuclease
domain of the human Werner syndrome protein was detected
(22). To characterize the biochemical properties of the WRN
exonuclease homologue AtWRNexo-p, we expressed the protein
in Escherichia coli. We could demonstrate that the protein is
indeed a 3 to 5 exonuclease with the preference for double-
stranded DNA with a 3-recessed or protruding strand. How-
ever, also significant differences in the processing of DNA
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substrates were found in comparison to the exonuclease activ-
ity of hWRN-p.
EXPERIMENTAL PROCEDURES
Materials and Enzymes—[-32P]ATP and [-32P]dCTP were pur-
chased from Amersham Biosciences. High performance liquid chroma-
tography-purified oligomers containing standard nucleotides were ob-
tained from Metabion (Martinsried, Germany); 8-oxoadenine (8-oxoA)-,
8-oxoguanine (8-oxoG)-, uracil (dU)-containing oligomers were from
Eurogentec (Liege, Belgium); and abasic site-, cholesterol-, hypoxan-
thine-, or ethenoadenine-containing oligomers from Midland (Midland,
TX). The sequences of synthetic oligonucleotides and the positions of
damaged bases are listed in Table I. Bacteriophage T4 polynucleotide
kinase and the Klenow fragment of E. coli DNA polymerase I were
purchased from New England Biolabs (Beverly, MA); leupeptin, benza-
midine, and 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride
were from Sigma; and lysozyme was from Roche Applied Science
(Mannheim, Germany).
DNA Labeling and Annealing—Single-stranded DNA oligomers were
5-end-labeled with [-32P]ATP (3000 Ci/mmol) using T4 polynucleotide
kinase (New England Biolabs) according to the manufacturer. To pro-
duce DNA substrates (see Table II), labeled oligomers were annealed to
the complementary strand in a 1:2 molar ratio in 70 mM Tris-HCl
buffer, pH 7.6, 10 mM MgCl2, incubated at 95 °C for 5 min, and then
slowly cooled to room temperature. The 3-end-labeled substrate was
produced by the annealing of 19-mer DNA to the 46-mer oligonucleotide
(1:2) and labeling the 3-end of 19-mer using [-32P]dCTP and Klenow
fragment of E. coli DNA polymerase I (New England Biolabs) according
to the manufacturer. Unincorporated labeled nucleotides were removed
from DNA-labeling reactions using MicroSpinTM G-50 columns (Amer-
sham Biosciences). DNA substrates were stored at 4 °C.
Expression and Purification of AtWRNexo Proteins—The AtWRNexo
ORF was cloned by ligation-independent cloning using an Affinity LIC
Cloning and Protein Purification kit (pCAL-n-FLAG, Stratagene) to
yield full-length AtWRNexo protein containing an N-terminal 27-aa
calmodulin-binding peptide (CBP) tag. CBP-AtWRNexo-p was overex-
pressed in the E. coli strain BL21(DE3) by 1 mM isopropyl--D-thioga-
lactopyranoside induction for 6 h at 25 °C. The purification procedure
followed the instructions of the manufacturer with some modifications.
The frozen cells were thawed and resuspended in lysis buffer (5 ml/g)
containing 750 mM NaCl, 50 mM Tris-HCl, pH 8.0, 2 mM CaCl2, 0.1%
Triton X-100, 10 mM -mercaptoethanol, and a mixture of protease
inhibitors. The lysozyme (200 g/ml) was added, and the suspension
was incubated with gently shaking on ice for 20 min. The cells were
further disrupted by sonication and centrifuged at 16,000  g for 20 min
at 4 °C. The lysate was then applied on a 2-ml CaM resin column
equilibrated in lysis buffer. The column was extensively washed with
ten volumes of lysis buffer, and two volumes of buffers were supple-
mented with proteases inhibitors and containing either 750 mM NaCl,
50 mM Tris-HCl, pH 8.0, 2 mM CaCl2, 10 mM -mercaptoethanol or 500
mM NaCl, 50 mM Tris-HCl, pH 8.0, 2 mM CaCl2, 10 mM -mercaptoeth-
anol. Proteins were eluted in elution buffer (500 mM NaCl, 50 mM
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Tris-HCl, pH 8.0, 2 mM EGTA, 10 mM -mercaptoethanol). Elution
fractions of 0.5 ml were collected and analyzed by SDS-PAGE. The
protein concentration was determined by the Bradford assay using
bovine serum albumin as a standard. The purified AtWRNexo-p was
supplemented with 100 g/ml bovine serum albumin and stored in
elution buffer containing 25% glycerol at 80 °C. The activity of At-
WRNexo-p remained stable for at least 3 months. AtWRNexoE135A-p
was purified in an identical fashion as used for AtWRNexo-p.
Production of pCAL-n-FLAG-AtWRNexoE135A—The point mutation
E135A (Glu 3 Ala at amino acid 135) was introduced by the
QuikChange site-directed mutagenesis kit from Stratagene according
to the manufacturer’s protocol using primers 5-GTT GGC TTG GAT
ATT GCG TGG AGA CCA AGT TTT AG-3 and 5-CTA AAA CTT GGT
CTC CAC GCA ATA TCC AAG CCA AC-3.
Exonuclease Assay—Reactions (10 l) were performed in reaction
buffer (40 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 5 mM dithiothreitol, 1 mM
ATP, and 0.1 mg/ml bovine serum albumin); for investigation of cation
requirements we used reaction buffer with pH 7.4 supplemented with
respective cations as indicated in Fig. 5. For the amounts of labeled
DNA substrates (DNA amounts are expressed in terms of molecules)
and AtWRNexo proteins see the figure legends. The reactions were
performed at 22 °C for 1 h, unless otherwise indicated, and terminated
by addition of an equal volume of denaturing loading buffer (89 mM Tris
borate, 2 mM EDTA, pH 8.0, 12% Ficoll, 0.01% bromphenol blue, 0.02%
xylene cyanol FF, 7 M urea; Bio-Rad), immediately heated at 98 °C for
3 min, analyzed on 20% polyacrylamide 1 TBE/7 M urea gel, and
visualized by autoradiography.
RESULTS
Expression and Purification of AtWRNexo-p and
AtWRNexoE135A-p—Our previous analysis indicated that an
ORF with similarity to only the exonuclease domain of hWRN
is present in the Arabidopsis genome. We reported about the
isolation of a cDNA that coded for an ORF of 285 amino acids
(22). Further detailed analysis indicated that beside this cDNA
a second slightly larger cDNA could also be amplified resulting
from an alternative splicing event of intron 5. This cDNA
contains an ORF that carries three amino acids more (Fig. 1)
than the sequence reported previously. An ORF encoding this
larger version of AtWRNexo was cloned into a bacterial vector
and used for further analysis. Amino acid sequence alignment
of AtWRNexo-p with the N terminus of the human WRN pro-
tein (Fig. 1) revealed conserved positions of all five amino acids
(Asp-133, Glu-135, Asp-194, Tyr-263, and Asp-267 in the Ara-
bidopsis thaliana sequence) regarded to be essential for exonu-
clease activity (16). The total identity between the N terminus
of the human WRN protein and AtWRNexo-p is 32% with a
similarity index of 45% (over 237 aa). At the far N terminus
AtWRNexo-p is 45 amino acids longer than the human WRN
protein (see Fig. 1). A point mutation from glutamic acid to
alanine at position 135 (E135A) corresponding to the amino
acid change E84A, previously shown to eliminate exonuclease
activity of the human WRN protein (23), was introduced into
the AtWRNexo ORF by site-directed PCR mutagenesis to
generate pCAL-n-FLAG-AtWRNexoE135A. Otherwise the
sequences of cloned fragments of AtWRNexo and AtWRN-
exoE135A were identical to the original cDNA of AtWRNexo.
The ORFs were inserted in-frame into the vector to allow the
production of calmodulin-binding peptide (CBP) fusion pro-
teins. Recombinant proteins were overexpressed in
E. coli and purified by one-step CaM affinity chromatography.
Purified AtWRNexo-p and AtWRNexoE135A-p had a molecular
mass of 37kDa, as expected from the calculated one, includ-
ing the additional N-terminal 27 amino acids of the CBP tag
and 14 aa translated from the vector sequence (Fig. 2).
AtWRNexo-p Has 3 3 5 Exonuclease Activity—To deter-
mine whether AtWRNexo-p has any exonuclease activity, a
duplex of an unlabeled 46-mer DNA oligonucleotide annealed
to either a 5-32P-labeled 20-mer or 3-32P-labeled 20-mer oli-
gonucleotide was used. A constant amount of AtWRNexo-p (100
fmol) was incubated at 22 °C with each DNA substrate (200
fmol) for different periods of time. In a second experiment, we
incubated the DNA substrates (200 fmol) with increasing
amounts of AtWRNexo-p. Digestion of 5-end-labeled DNA sub-
strates resulted in ladder-like patterns with labeled bands
becoming progressively smaller with increasing incubation
time and increasing enzyme concentration (Fig. 3, A and B). We
observed an accumulation of 2- to 6-nt fragments already after
15 min of digestion. The size of the fragments became smaller
(up to 2 nt) when incubation time was prolonged. When the
DNA substrate was incubated with 500–2000 fmol of AtWRN-
exo-p for 1 h even a very weak band corresponding to mono-
nucleotides was observed (Fig. 3B). Fragments of 3–6 nt could
be a result of the fact that at this length the DNA duplex may
dissociate under the conditions applied yielding non-digestible
single strands (see below). In contrast, incubation of AtWRN-
exo-p with a 3-end-labeled DNA substrate resulted, irrespec-
tive of the incubation time, besides the full-length substrate
that disappeared with time, only in a single band migrating as
a mononucleotide (Fig. 3, C and D). The intensity of degrada-
tion correlated with the amount of enzyme and the time of
incubation. These data indicate that AtWRNexo-p possesses no
DNA endonuclease activity and acts under the applied condi-
tions as an exonuclease digesting the DNA from the 3 to 5
end.
Activity of AtWRNexo-p on Different DNA Substrates—We
assayed AtWRNexo-p on different DNA substrates to deter-
mine its substrate requirements (Fig. 4). AtWRNexo-p hydro-
lyzes the recessed strand of DNA duplexes (see Fig. 3), as does
hWRN-p (9). The efficiency of degradation increased when the
reaction is performed at 37 °C (data not shown). Notably, we
FIG. 1. Amino acid sequence alignment of AtWRNexo-p with the N terminus of the WRN protein from human. The three extra amino
acids resulting from an alternative splicing event of intron 5 of AtWRNexo gene are underlined. Identical and conserved amino acids are shown
in dark bold characters, highly conserved amino acid stretches are represented as gray shaded boxes. The five amino acids thought to be critical
for exonuclease activity are dark shaded. The point mutation E135A that abolishes the exonucleolytic activity of AtWRNexo-p is marked with a
star. The total similarity between both protein sequences is 45%.
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observed that AtWRNexo-p is able to degrade also the protrud-
ing strand of the same DNA substrate (Fig. 4A). The result of
this degradation is a pattern of labeled oligonucleotides vary-
ing in length from 15 to 26 nucleotides dependent of the extent
of degradation of the recessed DNA strand. This is an impor-
tant difference to hWRN-p, which was reported to be unable to
degrade protruding strands of DNA duplexes (9).
Similar to hWRN-p, single-stranded DNA and double-
stranded DNA with blunt ends are hardly degraded
by AtWRNexo-p (Fig. 4, B and C). The mutant protein
AtWRNexoE135A-p was not able to process any of the sub-
strates tested, indicating that the observed activities belong
to the recombinant AtWRNexo-p and that this purified
protein is free of contaminating endo- or exonuclease
activities.
AtWRNexo-p Needs Mg2 or Mn2 for the Reaction and Is
Not Stimulated By ATP—The concentration and nature of di-
valent cations is influencing the specificity and efficiency of
various exonuclease reactions. We therefore assayed the activ-
ity of AtWRNexo-p in the presence of different divalent cations
(Fig. 5, see also “Experimental Procedures”). We found that the
presence of Mg2 is required for optimal exonucleolytic activity
of AtWRNexo-p. The activity remains stable even over the
broad range of ion concentration (90–95% of DNA substrate
degraded in the presence of 2–16 mM Mg2). Mg2 can be
partially substituted by Mn2 at lower concentrations (62–66%
of DNA substrate degraded in the presence of 2–6 mM Mn2).
Higher Mn2 concentrations have an inhibitory effect on the
exonuclease activity. Zn2 promotes only weak DNA degrada-
tion (only 23% of DNA was hydrolyzed at 4 mM Zn2). In the
presence of Ca2 no significant AtWRNexo-p activity was ob-
served. Cations alone were not responsible for DNA degrada-
tion, and AtWRNexoE135A-p was unable to process the DNA
even in presence of Mg2 (data not shown).
It was reported for hWRN-p that ATP stimulates the WRN
exonuclease activity on duplexes with 3-recessed ends (9). ATP
is required for structure-dependent binding of hWRN-p to
DNA, whereas its hydrolysis allows the exonucleolytic degra-
dation (15). However, another report demonstrated that ATP
hydrolysis is not required for and has no significant effect on
the hWRN-p exonuclease activity on DNA oligonucleotides that
form a bubble-like secondary structure (24). When we incu-
bated AtWRNexo-p with duplex DNA with a 3-recessed end
and tested the influence of ATP and its analogue with in-
creased metabolic stability, ATPS, on exonuclease activity, we
observed no difference in DNA substrate degradation (data not
shown). Quantification of the ratio between full-length oligo-
nucleotides and degradation products revealed no significant
differences. Between 6.5 and 7% of substrate remained undi-
gested in all cases.
The Processing of DNA Modifications and Bulky Lesions by
AtWRNexo-p—One can speculate that in vivo the exonuclease
activity of AtWRNexo-p might be required during the repair of
damaged DNA to remove damaged nucleotides. As described
for hWRN-p previously, certain damaged or modified nucleo-
tides incorporated into the DNA substrate inhibit or block the
exonucleolytic activity (19). To investigate a possible function
of AtWRNexo-p in DNA damage processing and to compare its
activities with those of hWRN-p, we tested the influence of
several types of DNA modifications on the exonucleolytic deg-
radation. We used dsDNA substrates with a 5-protruding tail,
which contained modifications in the labeled strands. These
modifications included helix-distorting lesions (apurinic site
and cholesterol adduct), minor base modifications (8-oxoG,
8-oxoA, and ethenoadenine), and unusual bases (uracil and
hypoxanthine). The sequences of oligonucleotides and the po-
sitions of respective modifications are shown in Table I. We
found that AtWRNexo-p is not inhibited by uracil and hypo-
xanthine (Fig. 6, A and C). Only weak inhibition at the position
3 to the modification could be observed using the substrate
with ethenoadenine (Fig. 6D). On the contrary, the exonuclease
is strongly inhibited by an apurinic site and completely blocked
by a cholesterol adduct (Fig. 6, C and D). AtWRNexo-p is also
inhibited by 8-oxoG and 8-oxoA at lower enzyme concentra-
tions. Higher enzyme concentrations allow the exonuclease to
pass the damaged nucleotide, in the case of 8-oxoA to a higher
degree (Fig. 6B). Importantly, AtWRNexo-p is able to start the
degradation of all DNA substrates. The unmodified substrate
was fully degraded after the same time of incubation using 100
fmol of AtWRNexo-p.
AtWRNexo-p Digests Recessed DNA Strands with 3-Termi-
nal-mismatched Nucleotides and Degrades DNA with Either a
Recessed 3-OH or a 3-PO4 Terminus to a Similar Extent—For
hWRN-p it was reported that its exonuclease, which is homol-
ogous to the 3 3 5 proofreading domain of E. coli DNA
polymerase I (25), preferentially digests the 3-recessed strand
with a single 3-mismatched nucleotide (9), suggesting a possi-
ble proofreading activity of hWRN-p during DNA replication.
We therefore tested AtWRNexo-p on DNA substrates con-
taining matched and one or two mismatched nucleotides on
the 3-recessed end (Fig. 7, A–C). We incubated 200 fmol of
DNA substrate with 100 fmol of either AtWRNexo-p or
AtWRNexoE135A-p for indicated periods of time at 22 °C. The
efficiency of degradation of single 3-mismatched nucleotide
was within the first 10 s about a third higher than that of the
complementary terminal nucleotide. Further time intervals re-
FIG. 2. SDS-PAGE analysis of bacterially expressed and purified
AtWRNexo-p and AtWRNexoE135A-p. Both proteins, AtWRNexo-p
(lane 1) and AtWRNexoE135A-p (lane 3) were purified by one-step calmod-
ulin (CaM)-affinity chromatography, electrophoresed (0.3 g) by 10% SDS-
PAGE, and stained with Bio-Safe Coomassie Blue. Lane 2 represents mo-
lecular markers, positions of molecular size marker proteins are indicated.
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vealed the similar extent of degradation for both matched and
a single 3-mismatched nucleotide. The hydrolysis of DNA con-
taining two 3-mismatched nucleotides was less efficient. After
15 min of the reaction only about 60% of the DNA substrate
was hydrolyzed (Fig. 7D). In comparison to hWRN-p, which
hardly degrades a 3-end with two terminal mismatches,
AtWRNexo-p seems to cleave such substrates, although with
lower efficiency.
To determine the ability of AtWRNexo-p to start the diges-
tion also from 3-PO4 termini, we incubated the DNA substrate
FIG. 3. AtWRNexo-p hydrolyzes DNA in 33 5 direction. DNA substrates (200 fmol), 32P-labeled either at the 5-end or at the 3-end of 20-mer, were
incubated with 100 fmol of AtWRNexo-p for the indicated periods of time (A and C) or with indicated amounts of AtWRNexo-p for 1h at 22 °C (B and D).
The length of single-stranded DNA present on each side of the duplex region is 13 nt. Products of DNA hydrolysis were resolved by electrophoresis on a 20%
polyacrylamide/7 M urea gel. The length of degraded fragments is indicated. It was determined using labeled DNA oligonucleotides of known lengths.
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containing a 3-PO4-recessed strand with 100 fmol of either
AtWRNexo-p or AtWRNexoE135A-p for the indicated periods
of time at 22 °C (Fig. 7E). The hydrolysis of the substrate by
AtWRNexo-p is similarly efficient for both types of termini (Fig.
7F). The same has been reported for hWRN-p (9).
DISCUSSION
Comparison of the Exonucleolytic Activities of AtWRNexo-p
and hWRN-p—A small ORF is present in the Arabidopsis
genome (AtWRNexo) with striking similarity to only the exo-
nuclease domain of the human Werner syndrome protein (22).
In this study we were able to demonstrate that the product of
the ORF indeed possesses exonuclease activity (see Fig. 1).
Using a one-step affinity chromatography-purified CBP-tagged
AtWRNexo protein (AtWRNexo-p) we have identified similari-
ties but also significant differences in the processing of DNA
substrates of AtWRNexo-p in comparison to the human Werner
exonuclease. Both possess 3 3 5 exonuclease activity cleav-
ing 3-recessed ends of partial dsDNA molecules. AtWRNexo-p
additionally digests protruding strands of duplexes. Single-
stranded DNA and double-stranded DNA with blunt ends are
poor substrates for both enzymes (this report and Refs. 9, 16,
and 17). Because AtWRNexo-p cleaves ssDNA only poorly,
digestion of 3-protruding strands apparently needs a double-
stranded region either to bind the enzyme or to stimulate the
exonucleolytic activity. Degradation of such substrates by only
the N-terminal part of human Werner syndrome protein (16,
26) revealed similar substrate specificities for the whole
hWRN-p and its N-terminal part.
Both, hWRN-p and AtWRNexo-p do not need ATP for their
exonuclease activity. However, in contrast to hWRN-p (9), no
FIG. 4. AtWRNexo-p hydrolyzes recessed and protruding strands in DNA duplexes. DNA substrates (200 fmol) were incubated with 100
fmol of either AtWRNexo-p or AtWRNexoE135A-p for the indicated periods of time at 22 °C. Products of DNA hydrolysis were resolved by
electrophoresis on a 20% polyacrylamide/7 M urea gel. Degradation of protruding strands (A), single-stranded DNA (B), and blunt-ended DNA (C).
The length of degraded fragments is indicated. It was determined using labeled DNA oligonucleotides of known lengths.
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stimulatory effect of ATP (even at protein to DNA molar ratios
of 0.05 or 0.1, data not shown) or PS on the AtWRNexo-p
activity on partial duplex DNA containing the 3-recessed end
was observed. This is most probably due to the absence of the
helicase/ATPase domain in AtWRNexo-p. The binding of ATP
to the helicase part of hWRN-p might also promote a confor-
mational change in the exonuclease domain, which could en-
hance the exonuclease activity.
The divalent ion Mg2 is required for the exonuclease reac-
tion. Mn2 is able to replace Mg2, Zn2 only partially, and
Ca2 not at all under the conditions used. The substitution of
Mg2 by Mn2 in reactions catalyzed by AtWRNexo-p is in
agreement with findings for hWRN-p, where Mn2 was able
not only to replace Mg2 but even to allow a more extensive
degradation of stem-loop DNA (15).
As for hWRN-p, the cholesterol adduct completely blocks
AtWRNexo-p, and uracil, hypoxanthine, and ethenoadenine
allow AtWRNexo-p to digest through the regions containing
these modifications (19). In contrast to hWRN-p, an apurinic
site strongly inhibits but not completely blocks the exonucleo-
lytic activity of AtWRNexo-p. Oxidative DNA lesions such as
8-deoxyadenine (8-oxoA) and 8-deoxyguanine (8-oxoG) inhibit
AtWRNexo-p, but such damaged nucleotides are removed at
high concentrations of the exonuclease. This is not the case for
hWRN-p (19).
hWRN-p degrades a DNA substrate with a single mis-
matched nucleotide at the 3-recessed terminus more effi-
ciently than a DNA with a 3-complementary terminal base;
however, DNA containing two mismatched nucleotides on the
3-recessed strand is poorly degraded (9), whereas AtWRNexo-p
hydrolyzes DNA substrates without or with a single mismatch with
almost similar efficiency. In contrast to hWRN-p, AtWRNexo-p is
able to digest a DNA substrate with two mismatched nucleotides at
the 3-recessed end, although at lower efficiency than substrates
without or only with one mismatch. This difference might be
caused by the absence of the helicase domain in AtWRNexo-p,
because another report (16) observed the comparable efficiency of
DNA degradation without and with a single mismatch and de-
creased efficiency of cleavage as the number of mismatches in-
creases when only the N-terminal part of hWRN-p was tested.
DNA double strand breaks can result in the formation of
3-recessed ends, terminating with either a 3-OH or a 3-PO4
group. Similar to hWRN-p (9), AtWRNexo-p is able to hydro-
lyze both kinds of substrates efficiently.
What Could Be the Reason(s) for the Different Activities of
AtWRNexo-p and hWRN-p?—In general our experiments show
that certain DNA structures are better substrates for AtWRNexop
than what has been reported on hWRN-p before, indicating a some-
how reduced substrate specificity of the plant enzyme in compari-
son to the human protein. This could be due to experimental limi-
tations of our approach, or might it indeed reflect a meaningful
biological difference. Although we cannot totally exclude the for-
mer, we favor the latter as the explanation.
One has to stress that in our experiments we used a 27-aa
N-terminal fusion of the AtWRNexo ORF to the calmodulin-
binding peptide (CBP) required for protein purification. Our
attempts to eliminate this fusion by peptidase digest were
always coupled with the precipitation of the enzyme, and there-
fore we were not able to perform experiments with a protein
without the respective tag. However, also in the experiments
with hWRN-p a protein fused to a N-terminal hexahistidine tag
and additional amino acids from the vector (a total of over 40
aa) was used for the biochemical characterization (9, 19). In
contrast to the studies with hWRN-p, we performed character-
ization of the exonuclease activity of AtWRNexo-p at 22 °C.
This is the optimal temperature for growth of A. thaliana.
Therefore, we assume that the peculiarities of the plant
enzyme are connected with its biological function(s). One has to
assume that the small protein interacts with other factors of
the repair and recombination machinery in plants and that in
the course of these interactions the specificity of the exonucle-
ase activity of AtWRNexo-p might be modulated. Indeed, two-
hybrid analysis revealed several proteins involved in DNA
repair and recombination that interact with AtWRNexo-p.2
Possible Roles of hWRN-p and AtWRNexo-p in DNA Metab-
olism—Beside its biochemical characterization, a question of
utmost importance is the possible role of the exonuclease in
vivo. Several in vitro studies indicated possible in vivo func-
tions of hWRN-p. hWRN-p is able to unwind intermediates in
DNA replication and repair processes (14), interacts with the
human 5-flap endonuclease/5 3 3 exonuclease, and stimu-
lates the cleavage activity of the latter (27, 28). The role of
hWRN-p in DNA replication is further supported by the finding
of interaction between hWRN-p and other proteins of the DNA
replication machinery, such as polymerase , proliferating cell
nuclear antigen, or replication protein A (13, 29–32). Xenopus
laevis FFA-1 protein, which is 66% homologous to hWRN-p, is
involved together with replication protein A in replication foci
formation (33). The hWRN-p exonuclease is also active on the
DNA substrates having on the 3-recessed strand mismatched
nucleotides (9, 16). It can be envisaged that misincorporated
nucleotides can be removed in manner of a 33 5 proofreading
exonuclease (34).
hWRN-p may also function in the repair of double strand
breaks by non-homologous end joining, because it was shown to
interact with Ku70/Ku80 (35, 36). Moreover, recent studies
revealed an interaction with DNA-PKcs, which forms together
with Ku70/Ku80 a complex involved in double strand break
repair. Displacement of DNA-PKcs from DNA was achieved by
addition of hWRN-p to a KuDNA-PKcsDNA complex, so that
the DNA-PKcs could no longer protect DNA ends from the
exonucleolytic action of hWRN-p (37). Ku70/Ku80 has been
found to stimulate the exonucleolytic activity of hWRN-p and
recruit hWRN-p to DNA (26, 36). Involvement of hWRN-p and
Ku in the same pathway is further supported by the observa-
tion of genetic instability, manifested by chromosomal translo-
cations, DNA breakage, and premature aging in Ku80 knock-
out mice (38). The coordinated activity of the helicase and the
exonuclease of the hWRN protein was investigated on forked
2 D. Zeuske, H. Plchova, I. Koturbash, F. Hartung, and H. Puchta,
unpublished results.
FIG. 5. AtWRNexo-p needs MgCl2 or MnCl2 for exonucleolytic
digestion. The duplex DNA (labeled oligonucleotide 1  oligonucleo-
tide 3, 200 fmol) was incubated with 100 fmol of AtWRNexo-p in the
presence of indicated concentrations of MgCl2, MnCl2, CaCl2, or ZnCl2
for 15 min at 22 °C. Products of DNA hydrolysis were resolved by
electrophoresis on a 20% polyacrylamide/7 M urea gel, and the ratio
between full-length oligonucleotide and degradation products was de-
termined by PhosphorImager analysis.
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FIG. 6. Exonucleolytic activity of AtWRNexo-p is markedly inhibited or blocked on substrates containing 8-oxoguanine (8-oxoG),
8-oxoadenine (8-oxoA), apurinic site, or cholesterol adduct. The DNA substrates (200 fmol) were incubated with indicated amounts of
AtWRNexo-p for 1 h at 22 °C. Products of DNA hydrolysis were resolved by electrophoresis on a 20% polyacrylamide/7 M urea gel. The DNA
sequences contain a modified base (uracil, 8-oxoG, 8-oxoA (A and B) and hypoxanthine, apurinic site, ethenoadenine, and cholesterol adduct (C and
D)), its respective position is indicated in light gray. The positions of the fragments representing the modifications is shown on the right side of the
figure. The length of degraded fragments is indicated. It was determined using labeled DNA oligonucleotides of known lengths.
A. thaliana Exonuclease Similarities to Werner Exonuclease 44135
FIG. 7. Exonucleolytic activity of AtWRNexo-p on DNA substrates with matched, one or two mismatched nucleotides at the
recessed 3 terminus and on DNA terminating with 3-PO4 group. The DNA substrates (A, B, C, and E) (200 fmol) were incubated with 100
fmol of either AtWRNexo-p or AtWRNexoE135A-p for the indicated periods of time at 22 °C. Products of DNA hydrolysis were resolved by
electrophoresis on a 20% polyacrylamide/7 M urea gel, and the ratio between full-length oligonucleotide and degradation products was determined
by PhosphorImager analysis (D and F). The extent of degradation of DNA with 3-PO4 group is compared with the DNA terminating with 3-OH
(D, see also Fig. 3A). Mismatched bases at the 3 terminus of the recessed DNA strand are indicated as black points. The length of degraded
fragments is indicated. It was determined using labeled DNA oligonucleotides of known lengths.
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FIG. 7—continued
A. thaliana Exonuclease Similarities to Werner Exonuclease 44137
duplexes containing telomeric repeats, and a possible role dur-
ing removal of recombination intermediates and telomere
maintenance was suggested (39). Indeed, a role for the
hWRN-p helicase in RAD51-dependent homologous recombina-
tion has been defined (40).
There is also some evidence that the hWRN protein might
participate in telomere maintenance. The hWRN protein was
shown to unwind a large telomere repeat DNA complex in the
presence of replication protein A (41). Another report describes
unwinding of tetrahelical structures of guanine-rich sequences
by Werner syndrome helicase (42). Helicase/exonuclease activ-
ities disrupt and degrade D-loops in vitro (43). D-loop struc-
tures occur in telomeric regions (44, 45) and are formed during
recombination. Thus, the loss of hWRN protein may lead to the
inability of cells to process D-loops in telomeres and therefore
to the loss of telomeric sequences. It was also shown that the
yeast WRN homologue Sgs1 is involved in telomere lengthen-
ing by a telomerase-independent pathway (46–48). Recent
studies described the stimulation of Werner helicase activities
by the telomere-binding protein TRF2 (49).
All these findings show that in humans WRN protein plays
an important role in the maintenance of genomic stability by its
involvement in the different processes of DNA metabolism,
such as replication, recombination, repair, or telomere mainte-
nance. The biological role of WRN homologues in plants re-
mains to be determined. The similarity of degradation of DNA
substrates with 3-recessed end, ssDNA, or dsDNA with blunt
ends supports the hypothesis that the Werner-like exonuclease
activities are a common feature of DNA metabolism in animals
and plants. Interactions of the AtWRNexo-p and several mem-
bers of the AtRecQl helicase family in the two-hybrid assay
(22)2 indicate that this exonuclease function is involved in
processes that require RecQl-helicase activities. Because this
exonuclease is not physically liked to a helicase, one is tempted
to speculate that it might be involved also in processes that do
not require helicase activities. Beside defining partners of the
exonuclease by two-hybrid screens, the analysis of transfer
DNA insertion lines will help us to elucidate the function of
AtWRNexo-p in vivo.
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